BRAF or NRAS Mutant Metastatic Melanoma (1)

Active, not recruiting (1)

phase 2 (1)

Pfizer (1)

mek162 (1)

drug (1)

Industry (1)

Interventional (1)

braf or nras mutant metastatic melanoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Nov 18, 2021